首页> 外文期刊>The journal of applied laboratory medicine. >Antiphospholipid Antibodies and the Antiphospholipid Syndrome: From Coagulation to the Clinic
【24h】

Antiphospholipid Antibodies and the Antiphospholipid Syndrome: From Coagulation to the Clinic

机译:Antiphospholipid抗体和Antiphospholipid综合症:从凝固诊所

获取原文
获取原文并翻译 | 示例
       

摘要

Antiphospholipid syndrome (APS) is a systemic, autoimmune disorder characterized by the presence of antiphospholipid antibodies (APLA) directed to various plasma proteins bound to anionic phospholipids. The clinical syndrome of APS is variable, resulting commonly in venous or arterial thrombosis and/or pregnancy morbidity and is defined by clinical and laboratory consensus criteria (1). "Noncriteria" clinical presentations and severe presentations such as catastrophic APS (a syndrome of multiorgan failure) are less common. Both criteria and noncriteria presentations are described in Table 1.
机译:Antiphospholipid综合征(APS)是一个系统,自身免疫性疾病的存在antiphospholipid抗体(APLA)指向各种血浆蛋白绑定到阴离子磷脂。变量,导致静脉或一般动脉血栓形成和/或妊娠发病率并被定义为临床和实验室(1)共识标准。演讲和严重的报告等灾难性的APS (multiorgan综合症失败)不太常见。noncriteria演讲中描述表1.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号